Orion presented the Results of our Successful Phase 1 Clinical Trial at the HIV Research for Prevention Conference
Ottawa, Canada January 27, 2021: Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering small protein therapeutics, today announced that they will